Japan's Nitto Denko To Acquire Girindas America For $12.6 Million
This article was originally published in PharmAsia News
Executive Summary
Nitto Denko of Japan said it would spend $12.6 million to buy all of U.S.-based Girindas America, third-largest contract maker of nucleic-acid drugs with ties to many European drug makers.